Clinical Trials on Intramural Haematoma of Thoracic Aorta

Total 992 results

University of Zurich

Unknown

Epidemiology and Outcome of Solitary Fibrous Tumors of the Pleura.

Solitary Fibrous Tumors of the Pleura

Switzerland
Centre Hospitalier Universitaire Dijon

Terminated

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours (EOLE)

Non-resectable Metastatic Cancer of the Lung | Non-resectable Metastatic Cancer of the Colon | Non-resectable Metastatic Cancer of the Rectosigmoid Junction | Non-resectable Metastatic Cancer of the Stomach | Non-resectable Metastatic Cancer of the Bile Duct | Non-resectable Metastatic Cancer... and other conditions

France
Shanghai Pulmonary Hospital, Shanghai, China
Zunyi Medical College; Ningbo HwaMei Hospital, Zhejiang, China; The First Affiliated...

Recruiting

Whole Slide Image for Predicting the Novel Grading System of Resected Lung Adenocarcinoma

Lung Adenocarcinoma | Whole Slide Image | Novel Grading System

China
Boehringer Ingelheim

Completed

Non-interventional Study for Real-world Data of Afatinib Treatment in First-line Setting and of Subsequent Therapies for Patients With Advanced Epidermal Growth Factor Receptor (EGFR) Mutation-positive Lung Adenocarcinoma

Non-squamous, Non-Small Cell Lung Cancer

Japan
Singapore General Hospital

Completed

Lung Nodule Prospective Database

Lung Neoplasms | Lung Cancer | Lung Adenocarcinoma

Singapore
Shanghai Chest Hospital

Completed

EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression

Lung Adenocarcinoma | EGFR Activating Mutation
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer

China
Betta Pharmaceuticals Co., Ltd.

Unknown

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer

China
Nikolaj Frost MD
Roche Pharma AG; Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus...

Recruiting

Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma (ANTELOPE)

Non-Small Cell Lung Cancer Metastatic

Germany
Shanghai Pulmonary Hospital, Shanghai, China

Completed

Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma

EGFR Gene Mutation | Lung Adenocarcinoma Stage III

China
Postgraduate Institute of Medical Education and...

Completed

Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy

Lung Diseases | Lung Cancer | Adenocarcinoma of Lung

India
The First Affiliated Hospital of Xiamen University

Unknown

18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma

Lung Adenocarcinoma | PET/CT | 18F-FDG | 68Ga-FAPI

China
Korean Association for the Study of Targeted Therapy
Chonnam National University Hospital; Kyungpook National University Hospital; Konkuk University Medical Center and other collaborators

Completed

Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001)

HER2 Gene Mutation | Adenocarcinoma Lung Stage IV

Korea, Republic of
Chinese PLA General Hospital

Unknown

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Neoplasms, Therapy-Associated

China
Swedish Medical Center
Pfizer

Completed

Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung Adenocarcinoma

Adenocarcinoma | Lung Cancer

United States
Children's Hospitals and Clinics of Minnesota
M.D. Anderson Cancer Center; Washington University School of Medicine; Dana-Farber... and other collaborators

Recruiting

International PPB/DICER1 Registry

Neuroblastoma | Thyroid Carcinoma | Pineoblastoma | Wilms Tumor | Embryonal Rhabdomyosarcoma | Ovarian Sarcoma | Sertoli-Leydig Cell Tumor | Pleuropulmonary Blastoma | Gynandroblastoma | DICER1 Syndrome | Cystic Nephroma | Renal Sarcoma | Nodular Hyperplasia of Thyroid | Nasal Chondromesenchymal Hamartoma | Ciliary Body... and other conditions

United States
Fayoum University Hospital

Recruiting

Mid-point Transverse Process to Pleura Block Versus Thoracic Paravertebral Block in Posterolateral Thoracotomy

Bronchiectasis | Lung Neoplasm | Emphysematous Bleb of Lung

Egypt
Fudan University

Recruiting

Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma (ECTOP-1004)

Lung Neoplasms

China
University of Colorado, Denver

Recruiting

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy

Non-Small Cell Lung Cancer | ALK Gene Mutation | EGFR Gene Mutation | BRAF V600E | Non-Small Cell Carcinoma of Lung, TNM Stage 4 | ROSE Cluster 1

United States
Liaoning Tumor Hospital & Institute

Not yet recruiting

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

NSCLC | EGF-R Positive Non-Small Cell Lung Cancer

China
Marina Garassino

Recruiting

Metformin Plus/Minus Fasting Mimicking Diet to Target the Metabolic Vulnerabilities of LKB1-inactive Lung Adenocarcinoma (FAME)

Advanced LKB1-inactive Lung Adenocarcinoma

Italy
Sichuan Provincial People's Hospital

Terminated

Stereotactic Body Radiation Therapy (SBRT) in Newly Diagnosed Advanced Staged Lung Adenocarcinoma (Sindas) (Sindas)

Stage IV EGFR Mutated Non-Small Cell Lung Cancer

China
The Clatterbridge Cancer Centre NHS Foundation...

Unknown

Investigation of an Abdominal Compression Device (ACE02)

Cancer of Stomach | Cancer, Lung

United Kingdom
OHSU Knight Cancer Institute
Oregon Health and Science University; Portland VA Medical Center

Completed

Exercise Program Among Lung Cancer Dyads (PEP-LC)

Depression | Quality of Life | Pain | Physical Activity | Lung Cancer | Lung Cancer Symptoms

United States
Peking University Cancer Hospital & Institute
Betta Pharmaceuticals Co., Ltd.

Unknown

Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC

EGFR Positive Non-Small Cell Lung Cancer,Adenocarcinoma

China
Myriad Genetic Laboratories, Inc.

Terminated

Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up (ONC003)

NSCLC | Lung Cancer | Lung Adenocarcinoma

United States
Zhejiang Cancer Hospital
Sun Yat-sen University

Unknown

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

Carcinoma of Lung | Small Cell | Limited Stage

China
Sanofi
Regeneron Pharmaceuticals

Completed

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Neoplasms, Lung | Pulmonary Diseases

United States, France, Canada
University Hospital, Strasbourg, France

Recruiting

Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.

NSCLC | IMMUNOTHERAPY | QUANTIFICATION OF CELL-FREE DNA

France
Groupe Français de Pneumo-Cancérologie
AstraZeneca

Active, not recruiting

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE) (OBSTINATE)

Non-Small Cell Lung Cancer

France
Mayo Clinic

Recruiting

Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma

Carcinoma, Squamous Cell | Lung Neoplasms | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Squamous Cell Carcinoma | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | Carcinoma, Squamous

United States
AC Camargo Cancer Center

Recruiting

Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors (EVENET)

Progression | Neuroendocrine Tumors | Neuroendocrine Tumor of the Lung | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1 | Neuroendocrine Tumor of Pancreas | Neuroendocrine Tumor Carcinoid

Brazil
University of Colorado, Denver

Completed

Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes

Marfan Syndrome | Turner Syndrome | Loeys-Dietz Syndrome | Thoracic Aortic Aneurysm and Dissection Syndromes | Ehlers-Danlos Type IV Syndrome

United States
David M. Ritter

Recruiting

Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)

Tuberous Sclerosis Complex | Lymphangioleiomyomatosis

United States
University of Pennsylvania
The LAM Foundation

Completed

Safety of Simvastatin in LAM and TSC (SOS)

Tuberous Sclerosis Complex | Lymphangioleiomyomatosis

United States
Erasmus Medical Center

Unknown

The Cognitive Variability in NF1 and TSC Monozygotic Twins (COVANTT)

Tuberous Sclerosis Complex | Neurofibromatosis Type I

Netherlands
Children's Hospital Medical Center, Cincinnati
Novartis

Completed

Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

Tuberous Sclerosis | Angiolipoma

United States
InCor Heart Institute
Novartis

Completed

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

Tuberous Sclerosis | Angiomyolipoma | Lymphangioleiomyomatosis

Brazil
Children's Hospital Medical Center, Cincinnati
Novartis Pharmaceuticals

Completed

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Tuberous Sclerosis | Lymphangioleiomyomatosis

United States
Children's Hospital Medical Center, Cincinnati
The LAM Foundation; Tuberous Sclerosis Alliance

Completed

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Tuberous Sclerosis | Lymphangioleiomyomatosis

United States
Fondazione IRCCS Istituto Nazionale dei Tumori,...
University of Campania "Luigi Vanvitelli"; Istituti Ospitalieri di Cremona; Istituto... and other collaborators

Recruiting

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

Cancer | NSCLC | Lung Cancer | Adenocarcinoma of Lung | Squamous Cell Lung Cancer

Italy
National Taiwan University Hospital

Completed

Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

Tumor Progression | EGFR Exon 19 Mutation

Taiwan
Robert Ramirez
Aadi Bioscience, Inc.

Terminated

A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System

Neuroendocrine Tumors

United States
Epizyme, Inc.

Completed

Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma

Mesothelioma | BAP1 Loss of Function

United States, United Kingdom, France
University Hospital, Essen

Completed

EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA (EGFRdelEx19)

Lung Adenocarcinoma Metastatic
First People's Hospital of Hangzhou

Unknown

A Study of Hypofractionated Radiotherapy for Limited Metastatic NSCLC Harboring Sensitizing EGFR Mutations After First Line TKI Therapy

Lung Adenocarcinoma | EGFR Positive Non-small Cell Lung Cancer
New Mexico Cancer Care Alliance
Genentech, Inc.

Terminated

Erlotinib and Standard Platinum-Based Chemotherapy for Newly Diagnosed, Advanced Non-Small Cell Carcinoma of the Lung

Carcinoma, Non-Small-Cell Lung

United States
Maria Sklodowska-Curie National Research Institute...
Medical University of Gdansk; The Greater Poland Cancer Centre; Medical University... and other collaborators

Completed

Prospective Study of Quality of Life in Non-small Cell Lung Cancer (NSCLC) Patients Treated With/Without Postoperative Radiotherapy

Non-Small Cell Lung Cancer

Poland
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After Crizotinib

Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Adenocarcinoma of the Lung | Large Cell Lung Cancer

United States
Fujian Cancer Hospital

Not yet recruiting

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

Lung Adenocarcinoma | PD-1 Inhibitor | Stage IV Non-small Cell Lung Cancer | VEGF

Clinical Trials on Intramural Haematoma of Thoracic Aorta

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations